Hosted on MSN18m
BTIG Downgrades Inari Medical (NARI)
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.
Fintel on MSN6h
BTIG Downgrades Palo Alto Networks (PANW)
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...
bovnews10h
What’s Fueling FiscalNote Holdings Inc (NOTE) Stock’s 5.23% Gain Above Its 200-Day SMA?
FiscalNote Holdings Inc (NOTE) stock saw a decline, ending the day at $1.33 which represents a decrease of $-0.04 or -2.92% from the prior close of $1.37. The stock opened at $1.45 and touched a low ...
Jasper Therapeutics price target lowered to $64 from $90 at BTIG
BTIG analyst Justin Zelin lowered the firm’s price target on Jasper Therapeutics (JSPR) to $64 from $90 and keeps a Buy rating on the shares ...
bovnews10h
BioNano Genomics Inc (BNGO) Stock Sees Market Value Hit $27.56 million: What Are the Implications?
On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.27 which represents a decrease of $-0.01 or -3.57% from the prior close of $0.28. The stock opened at $0.28 and ...
Chefs’ Warehouse price target raised to $58 from $50 at BTIG
BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $58 from $50 and keeps a Buy rating on the shares. The firm believes ...
Stock rally faces resistance: BTIG's Krinsky
The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...
Seeking Alpha16d
FREYR Battery jumps +50% over two trading sessions after BTIG upgrade
FREYR Battery (NYSE:FREY) rallied for a second consecutive session after BTIG upgraded the stock to a Buy rating. Last month, FREY announced it was acquiring a 5GW solar module facility in Texas ...
Investing19d
BTIG reiterates Buy on Humacyte stock as FDA approval of SYMVESS boosts commercialization prospects
On Friday, BTIG reaffirmed its Buy rating and $10.00 price target for Humacyte (NASDAQ:HUMA), currently trading at $3.46, following the Food and Drug Administration's approval of the company's ...
Yahoo Finance20d
Avalo Therapeutics initiated with a Buy at BTIG
https://www.tipranks.com/news/the-fly/streamline-health-expands-presence-in-texas-with-400-bed-health-system BTIG analyst Julian Harrison initiated coverage of Avalo ...
Investing21d
BTIG starts coverage on Real Brokerage stock, emphasizing differentiated model and no debt
On Wednesday, Real Brokerage Inc. (NASDAQ:REAX) was given a positive outlook by BTIG, as the firm started coverage on the company's stock with a Buy rating and a price target of $6.00. The firm ...
Seeking Alpha1mon
Onity Group upped to Buy at BTIG on better earnings visibility
BTIG upgraded Onity Group (NYSE:ONIT) stock to Buy from Neutral on Monday on the view its more stable leverage will improve earnings visibility. The mortgage loan company, formerly known as Ocwen ...